• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nrf2-lncRNA 通过调节依赖 p53 的 Nrf2 激活来控制细胞命运,作为 Plk2 和 p21 的 miRNA 海绵。

Nrf2-lncRNA controls cell fate by modulating p53-dependent Nrf2 activation as an miRNA sponge for Plk2 and p21.

机构信息

College of Pharmacy, Seoul National University, Seoul, South Korea.

Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, South Korea.

出版信息

FASEB J. 2019 Jul;33(7):7953-7969. doi: 10.1096/fj.201802744R. Epub 2019 Mar 21.

DOI:10.1096/fj.201802744R
PMID:30897343
Abstract

Long noncoding RNA (lncRNA) capable of controlling antioxidative capacity remains to be investigated. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a central molecule for cellular defense that increases antioxidative capacity. We identified a novel lncRNA named Nrf2-activating lncRNA () transcribed from an upstream region of the microRNA 122 gene (). existed in the cytoplasm, suggestive of its function as a competing endogenous RNA [ceRNA, microRNA (miRNA) sponge]. served as a ceRNA for polo-like kinase (Plk) 2 and cyclin-dependent kinase inhibitor 1 (p21) through binding of miRNA 128 and miRNA 224, inducing Plk2/Nrf2/p21 complexation for Nrf2 activation in the cells under p53-activating conditions (, DNA damage and serum deprivation). expression was suppressed with the initiation of apoptosis, being a rheostat for cell fate determination. levels correlated with the recurrence-free postsurgery survival rate of patients with hepatocellular carcinoma. Collectively, promotes Plk2 and p21 translation by competing for specific miRNAs and activating Nrf2 under surviving conditions from oxidative stress, implying that serves as a fine-tuning rheostat for cell fate decision.-Joo, M. S., Shin, S.-B., Kim, E. J., Koo, J. H., Yim, H., Kim, S. G. Nrf2-lncRNA controls cell fate by modulating p53-dependent Nrf2 activation as an miRNA sponge for Plk2 and p21.

摘要

长链非编码 RNA(lncRNA)能够控制抗氧化能力,但仍需研究。核因子红细胞 2 相关因子 2(Nrf2)是一种细胞防御的核心分子,可增加抗氧化能力。我们鉴定了一种新的 lncRNA,命名为 Nrf2 激活 lncRNA(),它来源于 microRNA 122 基因()的上游区域。存在于细胞质中,表明其作为竞争性内源性 RNA [ceRNA,microRNA(miRNA)海绵]的功能。通过结合 miRNA 128 和 miRNA 224,作为 polo 样激酶(Plk)2 和细胞周期蛋白依赖性激酶抑制剂 1(p21)的 ceRNA,诱导 Plk2/Nrf2/p21 复合物形成,在 p53 激活条件下(DNA 损伤和血清剥夺)激活 Nrf2。随着细胞凋亡的开始,表达受到抑制,成为细胞命运决定的变阻器。在具有肝细胞癌的患者中,表达水平与手术后无复发生存率相关。总之,在应激条件下,通过竞争特定的 miRNAs 促进 Plk2 和 p21 的翻译,并激活 Nrf2,表明 lncRNA 作为细胞命运决定的微调变阻器。-Joo,M. S.,Shin,S.-B.,Kim,E. J.,Koo,J. H.,Yim,H.,Kim,S. G. Nrf2-lncRNA 通过作为 Plk2 和 p21 的 miRNA 海绵来调节 p53 依赖性 Nrf2 激活来控制细胞命运。

相似文献

1
Nrf2-lncRNA controls cell fate by modulating p53-dependent Nrf2 activation as an miRNA sponge for Plk2 and p21.Nrf2-lncRNA 通过调节依赖 p53 的 Nrf2 激活来控制细胞命运,作为 Plk2 和 p21 的 miRNA 海绵。
FASEB J. 2019 Jul;33(7):7953-7969. doi: 10.1096/fj.201802744R. Epub 2019 Mar 21.
2
The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.GTP 酶 KRAS 通过激活癌细胞中 NRF2 调节的抗氧化防御系统来抑制肿瘤抑制因子 p53。
J Biol Chem. 2020 Mar 6;295(10):3055-3063. doi: 10.1074/jbc.RA119.011930. Epub 2020 Jan 30.
3
Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21 signaling in acute kidney injury.Plk2 介导的 Nrf2 磷酸化和转位通过 p53/Plk2/p21 信号通路激活急性肾损伤的抗炎作用。
Cell Biol Toxicol. 2023 Aug;39(4):1509-1529. doi: 10.1007/s10565-022-09741-1. Epub 2022 Jul 16.
4
The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells.p21(Waf1/Cip1)对DNA合成的允许作用取决于细胞类型:在p53失活的细胞中不存在这种作用。
Cell Signal. 2000 Jun;12(6):413-8. doi: 10.1016/s0898-6568(00)00081-4.
5
Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.乙型肝炎病毒X蛋白通过一条不依赖p53的途径上调p21waf1/cip1的表达并延长人肝癌细胞中G1期向S期的转变。
Oncogene. 2000 Jul 13;19(30):3384-94. doi: 10.1038/sj.onc.1203674.
6
Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.富含亮氨酸重复激酶2(LRRK2)使p53磷酸化并诱导p21(WAF1/CIP1)表达。
Mol Brain. 2015 Sep 18;8:54. doi: 10.1186/s13041-015-0145-7.
7
Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.p53转录程序中P-TEFb活性和RNA聚合酶II磷酸化的基因特异性需求。
Genes Dev. 2006 Mar 1;20(5):601-12. doi: 10.1101/gad.1398206.
8
A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cells.一种细胞周期蛋白依赖性激酶抑制剂(p21(WAF1/CIP1))影响人肝癌细胞中的胸苷掺入。
Br J Cancer. 2002 Feb 12;86(4):625-9. doi: 10.1038/sj.bjc.6600099.
9
Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.艰难梭菌毒素A诱导的结肠上皮细胞凋亡涉及通过p38丝裂原活化蛋白激酶的p53依赖性p21(WAF1/CIP1)诱导。
Gastroenterology. 2005 Dec;129(6):1875-88. doi: 10.1053/j.gastro.2005.09.011.
10
Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.Survivin、CDC25C和PLK1基因的间接p53依赖性转录抑制需要细胞周期蛋白依赖性激酶抑制剂p21/CDKN1A以及与DREAM复合物结合的CDE/CHR启动子位点。
Oncotarget. 2015 Dec 8;6(39):41402-17. doi: 10.18632/oncotarget.6356.

引用本文的文献

1
The impact of oxidative stress and the NRF2-KEAP1-ARE signaling pathway on anticancer drug resistance.氧化应激和NRF2-KEAP1-ARE信号通路对抗癌药物耐药性的影响。
Oncol Res. 2025 Jul 18;33(8):1819-1834. doi: 10.32604/or.2025.065755. eCollection 2025.
2
A Novel ceRNA Axis LOC121818100/Novel-miR-400/SSRP1 Regulated Muscle Growth and Injury Repair in Sheep.一种新型ceRNA轴LOC121818100/新型-miR-400/SSRP1调控绵羊肌肉生长和损伤修复
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13836. doi: 10.1002/jcsm.13836.
3
Identification and development of TP53 mutation-associated Long non-coding RNAs signature for optimized prognosis assessment and treatment selection in hepatocellular carcinoma.
鉴定和开发与 TP53 突变相关的长非编码 RNA 标志物,用于优化肝细胞癌的预后评估和治疗选择。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231211795. doi: 10.1177/03946320231211795.
4
LncRNAs associated with oxidative stress in diabetic wound healing: Regulatory mechanisms and application prospects.与糖尿病伤口愈合中氧化应激相关的长链非编码 RNA:调控机制及应用前景。
Theranostics. 2023 Jun 26;13(11):3655-3674. doi: 10.7150/thno.85823. eCollection 2023.
5
Polo-Like Kinase 2: From Principle to Practice.波罗样激酶2:从理论到实践
Front Oncol. 2022 Jul 8;12:956225. doi: 10.3389/fonc.2022.956225. eCollection 2022.
6
Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21 signaling in acute kidney injury.Plk2 介导的 Nrf2 磷酸化和转位通过 p53/Plk2/p21 信号通路激活急性肾损伤的抗炎作用。
Cell Biol Toxicol. 2023 Aug;39(4):1509-1529. doi: 10.1007/s10565-022-09741-1. Epub 2022 Jul 16.
7
Stressing the Regulatory Role of Long Non-Coding RNA in the Cellular Stress Response during Cancer Progression and Therapy.强调长链非编码RNA在癌症进展和治疗过程中细胞应激反应中的调节作用。
Biomedicines. 2022 May 23;10(5):1212. doi: 10.3390/biomedicines10051212.
8
Molecular and functional heterogeneity in dorsal and ventral oligodendrocyte progenitor cells of the mouse forebrain in response to DNA damage.在应对 DNA 损伤时,小鼠前脑背侧和腹侧少突胶质前体细胞的分子和功能异质性。
Nat Commun. 2022 Apr 28;13(1):2331. doi: 10.1038/s41467-022-30010-6.
9
Long Non-coding RNA ZFPM2-AS1: A Novel Biomarker in the Pathogenesis of Human Cancers.长链非编码 RNA ZFPM2-AS1:人类癌症发病机制中的新型生物标志物。
Mol Biotechnol. 2022 Jul;64(7):725-742. doi: 10.1007/s12033-021-00443-3. Epub 2022 Jan 31.
10
Comprehensive analysis of lncRNAs involved in skeletal muscle development in ZBED6-knockout Bama pigs.ZBED6 敲除巴马猪骨骼肌发育相关长链非编码 RNA 的综合分析。
BMC Genomics. 2021 Aug 4;22(1):593. doi: 10.1186/s12864-021-07881-y.